Survey Finds Americans Value Sleep Differently Based on Age, Income, and Attitudes
A new study of 455 US adults surveyed at the SLEEP 2026 annual meeting found that people assign different financial values to sleep. The research linked these valuation differences to demographic and personal factors including age, income, and existing beliefs about sleep. The findings suggest that sleep's perceived worth varies significantly across populations, which could inform public health messaging and sleep-related interventions.
Researchers presenting at the SLEEP 2026 annual meeting conducted a survey of 455 US adults to examine how people financially value sleep. The study found substantial variation in how much monetary worth individuals assign to sleep, with these differences correlating to several key factors. Age, income level, and pre-existing attitudes toward sleep all emerged as significant predictors of how people value rest. The research suggests that sleep's perceived economic and personal value is not uniform across the population, but rather shaped by demographic characteristics and individual beliefs. Understanding these valuation differences could have implications for designing targeted health interventions and public health campaigns around sleep.
What's missing
The specific methodology for assigning financial values to sleep, the actual dollar amounts or ranges respondents provided, and the statistical significance of the correlations found are not detailed in the available source material.
What different sources said
- Medical XpressCenter
Sleep gets price tag in new survey of 455 US adults
Related
Sydney Psychiatrist Retains Medical License After Sexual Assault Conviction
Gopi Ilawala, a Sydney psychiatrist convicted of sexually assaulting an intoxicated colleague in 2022, has been allowed to continue practicing medicine despite the state health regulator seeking to have his registration cancelled. The New South Wales Civil and Administrative Tribunal reprimanded him and imposed conditions rather than striking him off, citing his remorse, lack of prior convictions, and support from two senior psychiatrists. The decision raises questions about professional accountability and public protection in medical regulation.
Australia's TGA to crack down on illegal peptides; government allocates $100m for arthritis research
Australia's Therapeutic Goods Administration has announced a crackdown on illegal peptides due to a surge in imports and online advertising, designating them a priority focus area. The federal government has simultaneously committed $100 million to medical research into arthritis prevention, diagnosis, and treatment. These developments reflect growing regulatory concerns about unregulated drugs and increased investment in chronic disease research.
GLP-1 Drugs Like Ozempic May Help ADHD Symptoms, According to Patient Reports and Clinical Observations
Social media users and some patients are reporting that GLP-1 receptor agonist drugs like Ozempic appear to improve ADHD symptoms, including increased focus, reduced procrastination, and better impulse control. GLP-1s were originally developed to treat Type 2 diabetes but are being studied for various other conditions. While anecdotal reports are growing, no formal clinical trials are currently testing these drugs specifically for ADHD, and the mechanism behind any potential benefit remains unclear.